<DOC>
	<DOCNO>NCT00099944</DOCNO>
	<brief_summary>Many people type 2 diabetes maintain target blood glucose level take single oral drug . The purpose study assess safety effectiveness two dos vildagliptin , unapproved drug , lower overall blood glucose level add glimepiride people type 2 diabetes target blood glucose level sulfonylurea alone .</brief_summary>
	<brief_title>Efficacy Safety Vildagliptin Combination With Glimepiride Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<criteria>Blood glucose criterion must meet Previously treat sulfonylurea least 3 month Body mass index ( BMI ) range 2245 Type 1 diabetes Pregnancy lactation Evidence serious cardiovascular complication Evidence serious diabetic complication Laboratory value abnormality define protocol Known sensitivity glimepiride Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>vildagliptin</keyword>
</DOC>